- Home
- BPTH vs PAPL Comparison
BPTH vs PAPL Comparison
Compare BPTH & PAPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPTH
- PAPL
- Stock Information
- Founded
- BPTH 2007
- PAPL 2015
- Country
- BPTH United States
- PAPL Canada
- Employees
- BPTH N/A
- PAPL N/A
- Industry
- BPTH Biotechnology: Pharmaceutical Preparations
- PAPL Finance: Consumer Services
- Sector
- BPTH Health Care
- PAPL Finance
- Exchange
- BPTH Nasdaq
- PAPL Nasdaq
- Market Cap
- BPTH 4.8M
- PAPL 4.4M
- IPO Year
- BPTH N/A
- PAPL 2023
- Fundamental
- Price
- BPTH $0.73
- PAPL $0.48
- Analyst Decision
- BPTH Strong Buy
- PAPL Strong Buy
- Analyst Count
- BPTH 2
- PAPL 2
- Target Price
- BPTH $30.00
- PAPL $5.25
- AVG Volume (30 Days)
- BPTH 161.7K
- PAPL 455.1K
- Earning Date
- BPTH 03-07-2025
- PAPL 01-21-2025
- Dividend Yield
- BPTH N/A
- PAPL N/A
- EPS Growth
- BPTH N/A
- PAPL N/A
- EPS
- BPTH N/A
- PAPL N/A
- Revenue
- BPTH N/A
- PAPL $2,885,706.00
- Revenue This Year
- BPTH N/A
- PAPL $22.61
- Revenue Next Year
- BPTH N/A
- PAPL $30.00
- P/E Ratio
- BPTH N/A
- PAPL N/A
- Revenue Growth
- BPTH N/A
- PAPL 32.40
- 52 Week Low
- BPTH $0.59
- PAPL $0.41
- 52 Week High
- BPTH $10.00
- PAPL $2.14
- Technical
- Relative Strength Index (RSI)
- BPTH 37.30
- PAPL 45.69
- Support Level
- BPTH $0.78
- PAPL $0.47
- Resistance Level
- BPTH $0.84
- PAPL $0.52
- Average True Range (ATR)
- BPTH 0.05
- PAPL 0.05
- MACD
- BPTH -0.02
- PAPL -0.00
- Stochastic Oscillator
- BPTH 4.05
- PAPL 17.86
About BPTH Bio-Path Holdings Inc.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. The other drugs of the company are BP1002, BP1003, BP1001-A, and DNABILIZE.
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.